Efficacy of Obturator Nerve Block During Transurethral Resection on Non-muscle Invasive Intermediate and High Risk Lateral Wall Bladder Tumours: A Prospective Randomized Controlled Study
- 1 November 2022
- journal article
- research article
- Published by Maad Rayan Publishing Company
- Vol. 19 (6) , 445-451
Abstract
Purpose: We aimed to investigate the effects of obturator nerve block (ONB) on obturator reflex, incomplete resection, perforation, progression and recurrence of tumor, presence of muscle tissue in the specimen, need for a second transurethral resection (TURBT) of bladder tumors, and postoperative complications in patients who underwent TURBT for intermediate-high risk lateral wall non-muscle invasive bladder cancers (NMIBC). Material and Methods: Patients were assigned to one of two groups by drawing lots: ONB or no ONB. Early and late recurrence, tumor progression, obturator reflex beat, incomplete resection, perforation, presence of muscle layer in pathology, second TURBT application, operation time, postoperative hospital stay, and complications were compared between the two groups. Results: The median follow-up time of study was 32 (23-41) months. Interquartile range (IQR) was 9. Tumor recurrence at the 3rd month cystoscopy was observed in 5 (9.8%) patients in the ONB group, while it was observed in 11 (20.8%) patients in the nONB group (P = 0.01). Late tumor recurrence was observed in 10 patients (19.6%) in the ONB group, and in 20 patients (37.7%) in the nONB group (P = 0.041). The RFS rate at 12th month was 84% in the ONB group, 69% in the nONB group, 79% in the ONB group at 36th month, and 58% in the nONB group at 36 months, the PFS rate was 94% in the ONB group, while it was 85% in the nONB group (P = 0.041). Conclusion: Our study showed that ONB decreases the early and late recurrence and increases recurrence free survival in patients with intermediate-high risk lateral wall bladder cancer.Keywords
This publication has 17 references indexed in Scilit:
- European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 UpdateEuropean Urology, 2019
- Quality Control Indicators for Transurethral Resection of Non–Muscle-Invasive Bladder CancerClinical Genitourinary Cancer, 2019
- Effect of obturator nerve block during transurethral resection of lateral bladder wall tumors on the presence of detrusor muscle in tumor specimens and recurrence of the diseaseThe Kaohsiung Journal of Medical Sciences, 2016
- EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-GuérinEuropean Urology, 2016
- The Economics of Bladder Cancer: Costs and Considerations of Caring for This DiseaseEuropean Urology, 2014
- Segunda resección transuretral y pronóstico del cáncer de vejiga no músculo-invasivo de alto grado en pacientes que no reciben bacilo de Calmette-GuérinActas Urológicas Españolas, 2014
- Perforation during TUR of bladder tumours influences the natural history of superficial bladder cancerWorld Journal of Urology, 2013
- Ultrasound guided obturator nerve block: a single interfascial injection techniqueJournal of Anesthesia, 2011
- Transvesical Blockade of the Obturator Nerve to Prevent Adductor Contraction in Transurethral Bladder SurgeryJournal of Endourology, 2010
- Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC TrialsEuropean Urology, 2006